Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.
about
Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyBacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccineImmunotherapy for bladder cancer.Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder.NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell ActivationCord factor and peptidoglycan recapitulate the Th17-promoting adjuvant activity of mycobacteria through mincle/CARD9 signaling and the inflammasome.Future directions in bladder cancer immunotherapy: towards adaptive immunity.Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area?Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancerTreatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach.New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review.Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.Next-Generation Vaccines Based on Bacille Calmette-Guérin.
P2860
Q26798372-87C31156-8DB1-48AA-97F2-872C856F41E1Q27006765-EF7C31D2-A613-42BB-A9C6-36F21DF047D9Q34477444-62D24FF0-1A9B-4FF6-948D-175814614A1CQ35156055-EDF3B996-3677-4E15-98B4-4D56C6019D5CQ35693194-77F2C00F-AA9D-4D49-A666-4D2C717023B9Q37037287-E64775F0-1546-4543-BD9E-A38707BF29B6Q38727522-ECEDA3E9-A696-4905-AE11-801856CDDA39Q38961435-CEDDBE98-E948-4CB9-A795-094E031DB350Q40952077-AB563CC1-DDB9-4AB2-83BB-5DFB2161A94EQ41016369-74624E4A-9803-4B2A-89B6-8BF443931C00Q44218570-C240759D-2FDE-42CF-865A-EE3F77F46979Q47160106-A2B9C97F-E5DF-416D-BE9C-96801D2EF889Q47655009-59229BFD-00F3-4266-A5F8-88C586461478Q49829375-A3DAC8BE-71F6-4EB1-B3AB-C54F5611B515
P2860
Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Th1 cytokine-secreting recombi ...... munotherapy of bladder cancer.
@ast
Th1 cytokine-secreting recombi ...... munotherapy of bladder cancer.
@en
type
label
Th1 cytokine-secreting recombi ...... munotherapy of bladder cancer.
@ast
Th1 cytokine-secreting recombi ...... munotherapy of bladder cancer.
@en
prefLabel
Th1 cytokine-secreting recombi ...... munotherapy of bladder cancer.
@ast
Th1 cytokine-secreting recombi ...... munotherapy of bladder cancer.
@en
P2860
P921
P356
P1476
Th1 cytokine-secreting recombi ...... mmunotherapy of bladder cancer
@en
P2093
Jonathan Henning
P2860
P304
P356
10.1155/2011/728930
P5008
P577
2011-09-15T00:00:00Z